Eye Movement Desensitisation and Reprocessing (EMDR) to Improve Mental Health Following Intensive Care Admission (EMERALD)
Post Traumatic Stress Disorder, Critical Illness, Eye Movement Desensitisation and Reprocessing
About this trial
This is an interventional treatment trial for Post Traumatic Stress Disorder focused on measuring EMDR, Feasibility, Acceptability
Eligibility Criteria
Inclusion Criteria:
- Survivors of an intensive care admission, who have received level 3 care for >24 hours.
- Aged ≥18 years
- Capacity to provide informed consent and complete trial interventions and assessments.
Exclusion Criteria:
- Pre-existing cognitive impairment such as dementia
- Pre-existing diagnosis of psychosis
- Not expected to survive post-hospital discharge
- Traumatic brain injury
Sites / Locations
- University Hospitals Dorset
- University Hospital SouthamptonRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
No Intervention
Control
Eye Movement Desensitisation and Reprocessing
Observation
Participants who exhibit symptoms of PTSD and are randomised to the control group, will receive usual care offered by their hospital.
Participants who exhibit symptoms of PTSD and are randomised to the intervention group, will receive EMDR plus usual care offered by their hospital. EMDR will be delivered by trained and accredited psychological therapists, employed by National Health Service community mental health teams.
Participants who do not exhibit symptoms of PTSD will receive usual care offered by their hospital and repeat the psychological assessment at 12-months post-hospital discharge.